New HIV Treatment Option For Tackling Drug Resistance in the Pipeline
New HIV Treatment Option For Tackling Drug Resistance in the Pipeline By Mary Hearty The European Commission has granted Marketing Authorization for Sunlenca® (lenacapavir), a new treatment option in the form of injection and tablets for people with HIV infection, whose virus no longer effectively responds to their current therapy. The new treatment is used in combination […]



